Product
Immune Suppressant
1 clinical trial
4 indications
Indication
FinerenoneIndication
IgA NephropathyIndication
ProteinuriaIndication
Safety IssuesClinical trial
Study of the Clinical Efficacy and Safety of Finerenone for the Treatment of IGAStatus: Completed, Estimated PCD: 2024-03-31